SCHEMBL7202918

SCHEMBL7202918

Brc1c(NN2C=NCC2)ccc2scnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7202843 0.84 — —
SCHEMBL7201952 0.81 — —
SCHEMBL7202916 0.69 RIPK2 (0.33) —
SCHEMBL7202913 0.68 ADRA2A (0.62) —
SCHEMBL7207384 0.68 — —
SCHEMBL1669608 0.67 ADRA2A (0.41) —
SCHEMBL6142191 0.66 ADRA2A (0.31) —
SCHEMBL31390036 0.62 ALDH1A1 (0.33) —
SCHEMBL31389476 0.62 ALDH1A1 (0.33) —
SCHEMBL31389690 0.62 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998023612-A1 2-IMIDAZOLINYLAMINOBENZOTHIAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 — — WO claimed
US-6610720-B2 Administering to the patient an alpha-2 adrenoreceptor agonist for the treatment or prevention of emesis MERCK FROSST CANADA & CO. (CA) 2003-08-26 — — US disclosed
US-20020045565-A1 Method for treating or preventing emesis MERCK FROSST CANADA LTD. (CA) 2002-04-18 — — US disclosed
WO-1998023612-A1 2-IMIDAZOLINYLAMINOBENZOTHIAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 — — WO disclosed
Send feedback